Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #19339 on Protagenic Therapeutics Inc. (PTIX)
vlftraders
01/23/12 12:42 PM
#19341 RE: RSDS u308 #19339
NinjaAssassin
01/23/12 12:43 PM
#19342 RE: RSDS u308 #19339
Item 2.06 Material Impairments. The officers of the Company have concluded that a charge for impairment of approximately $1,200,000 is required under generally accepted accounting principles applicable to the Company, which charge will be reflected in the Company’s financial statements for the fiscal year ended December 31, 2011. The impairment charge will not result in any cash expenditures by the Company. The charge is being incurred in connection with the termination of that certain Master Services Agreement by and between the Company and Brilliant Digital Entertainment, Inc., dated March 26, 2010, as amended, and the termination of that certain Marketing Services Agreement by and between the Company and Brilliant Digital Entertainment, Inc., dated March 26, 2010, as amended, which terminations were previously reported on the Company’s Current report on Form 8-K filed with the Securities and Exchange Commission on December 29, 2011. The agreements were previously recorded as intangible assets on the Company’s balance sheet and the Company has determined that the assets have no further value.